Science News
from research organizations

Kidney disease: Report assesses mammoth problem for the United States

Medicare spends billions per year; researchers hope to cut costs, improve care

Date:
March 30, 2016
Source:
University of Virginia Health System
Summary:
A sweeping new report assessing chronic kidney disease in the United States offers startling statistics about a condition that affects almost 14 percent of the US population and costs billions in Medicare spending each year.
Share:
FULL STORY

A sweeping new report assessing chronic kidney disease in the United States offers startling statistics about a condition that affects almost 14 percent of the U.S. population and costs billions in Medicare spending each year.

"This report is a one-stop shop to try to understand the prevalence of kidney disease, how it's being treated and how the burden affects various populations," said researcher Rajesh Balkrishnan, PhD, of the University of Virginia School of Medicine. "If we can identify which treatment modalities are working and how they're used and link these treatments to outcomes, we can inform the government of the most cost-effective ways to manage and treat the growing burden of kidney disease in the U.S."

Underappreciated Ailments

The massive, two-volume report looks at both chronic kidney disease -- the loss of kidney function over time -- and potentially deadly kidney failure, known as end-stage renal disease. In 2013, Medicare spending for end-stage renal disease increased to $31 billion, in addition to $50 billion spent on chronic kidney disease among those 65 and older.

Balkrishnan, of UVA's Department of Public Health Sciences, led the report's analysis of prescription drug use and cost. His findings include:

  • In 2013, spending on prescriptions for Medicare Part D patients with chronic kidney disease was 46 percent higher than for general Medicare patients ($3,675 per patient versus $2,509).
  • Spending for prescriptions for Part D patients with end-stage renal disease was significantly greater still: At $6,673 per patient per year, spending was 2.6 times higher than for general Medicare patients. Dialysis patients had the greatest cost, $7,142 per person per year.
  • Spending for Part D-covered medications was more than twice as high for chronic kidney disease patients who received Medicare's low-income subsidy than for those who didn't ($6,088 versus $2,873). Out-of-pocket costs were only 1 percent to 2 percent for patients who received the subsidy, while patients who didn't receive the subsidy paid 28 percent to 32 percent.
  • More than 69 percent (69.4 percent) of Medicare patients with chronic kidney disease were enrolled in Medicare Part D. More than 74 percent (74.2 percent) of patients with end-stage renal disease were enrolled in Part D.

Balkrishnan hopes the report will inform national healthcare policy and improve the quality of care for patients with kidney disease. "Our goal is to provide a snapshot view of the major issues in the diagnosis and treatment of kidney disease in the U.S.," Balkrishnan said. "There are definitely gaps there in the treatment of many patients, which can be improved upon."


Story Source:

Materials provided by University of Virginia Health System. Note: Content may be edited for style and length.


Journal Reference:

  1. Rajiv Saran, Yi Li, Bruce Robinson, Kevin C. Abbott, Lawrence Y.C. Agodoa, John Ayanian, Jennifer Bragg-Gresham, Rajesh Balkrishnan, Joline L.T. Chen, Elizabeth Cope, Paul W. Eggers, Daniel Gillen, Debbie Gipson, Susan M. Hailpern, Yoshio N. Hall, Kevin He, William Herman, Michael Heung, Richard A. Hirth, David Hutton, Steven J. Jacobsen, Kamyar Kalantar-Zadeh, Csaba P. Kovesdy, Yee Lu, Miklos Z. Molnar, Hal Morgenstern, Brahmajee Nallamothu, Danh V. Nguyen, Ann M. O’Hare, Brett Plattner, Ronald Pisoni, Friedrich K. Port, Panduranga Rao, Connie M. Rhee, Ankit Sakhuja, Douglas E. Schaubel, David T. Selewski, Vahakn Shahinian, John J. Sim, Peter Song, Elani Streja, Manjula Kurella Tamura, Francesca Tentori, Sarah White, Kenneth Woodside, Richard A. Hirth. US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. American Journal of Kidney Diseases, 2016; 67 (3): A7 DOI: 10.1053/j.ajkd.2015.12.014

Cite This Page:

University of Virginia Health System. "Kidney disease: Report assesses mammoth problem for the United States: Medicare spends billions per year; researchers hope to cut costs, improve care." ScienceDaily. ScienceDaily, 30 March 2016. <www.sciencedaily.com/releases/2016/03/160330103326.htm>.
University of Virginia Health System. (2016, March 30). Kidney disease: Report assesses mammoth problem for the United States: Medicare spends billions per year; researchers hope to cut costs, improve care. ScienceDaily. Retrieved May 23, 2017 from www.sciencedaily.com/releases/2016/03/160330103326.htm
University of Virginia Health System. "Kidney disease: Report assesses mammoth problem for the United States: Medicare spends billions per year; researchers hope to cut costs, improve care." ScienceDaily. www.sciencedaily.com/releases/2016/03/160330103326.htm (accessed May 23, 2017).

RELATED STORIES